{"id":"W4389685271","doi":"10.1038/s41591-023-02679-9","title":"Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institutes of Health; St. Jude Medical; Assistance publique-Hôpitaux de Paris; MyoKardia; Innovationsfonden; Boston VA Research Institute; Regado Biosciences; Wellcome Trust; Cleveland Clinic; Boston Scientific Corporation; Duke Clinical Research Institute; Novo Nordisk; American Heart Association; Daiichi Sankyo Europe; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Proarrhythmia; Atrial fibrillation; Cardioversion; Clinical endpoint; Placebo; Randomized controlled trial; Adverse effect; Anesthesia; Sinus rhythm; Internal medicine; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001741734,0.0001626053,0.0008840721,0.0004508986,0.00005442836,0.000004920716,0.00006866039,0.0002707028,0.0002145788],"category_scores_gemma":[0.003625422,0.00009033267,0.0004240146,0.001581392,0.0001827806,0.00006388449,0.00005723793,0.0003636566,0.00001468751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004753305,"about_ca_system_score_gemma":0.00006777533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002477544,"about_ca_topic_score_gemma":0.000008549533,"domain_scores_codex":[0.9979491,0.0002184322,0.0007271166,0.0002218207,0.0006885673,0.0001949578],"domain_scores_gemma":[0.9985756,0.0006777665,0.0002982283,0.0002796126,0.0001083836,0.00006042004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9726492,0.00001725917,0.002202232,0.000217861,0.0002391084,0.0000391796,0.001182426,0.000245043,0.002662275,0.003076348,0.01321858,0.004250483],"study_design_scores_gemma":[0.9808666,0.0003865074,0.002885784,0.000338579,0.0003904712,0.000005037797,0.0001735402,0.002189472,0.0006803147,0.001491921,0.01048894,0.0001027939],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9183056,0.001397291,0.00006682021,0.06776692,0.004653519,0.004164158,0.000009368918,0.0001306417,0.003505669],"genre_scores_gemma":[0.9881276,0.0002092302,0.00002268548,0.0003532351,0.009110052,0.000004882666,0.000143251,0.00001727781,0.002011736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06982204,"threshold_uncertainty_score":0.4340231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03903936154391102,"score_gpt":0.362225024930335,"score_spread":0.323185663386424,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}